Perpetual Ltd Has $2.99 Million Position in Express Scripts Holding Company (ESRX)

Perpetual Ltd increased its stake in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 2.2% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 46,899 shares of the company’s stock after acquiring an additional 1,000 shares during the period. Perpetual Ltd’s holdings in Express Scripts Holding were worth $2,994,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ESRX. Dodge & Cox raised its holdings in Express Scripts Holding by 25.7% during the second quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock worth $2,310,275,000 after acquiring an additional 7,388,021 shares in the last quarter. Pzena Investment Management LLC bought a new stake in Express Scripts Holding during the second quarter worth about $181,234,000. Renaissance Technologies LLC raised its holdings in Express Scripts Holding by 9,353.3% during the first quarter. Renaissance Technologies LLC now owns 1,308,239 shares of the company’s stock worth $86,226,000 after acquiring an additional 1,294,400 shares in the last quarter. Baupost Group LLC MA bought a new stake in Express Scripts Holding during the first quarter worth about $80,978,000. Finally, Northern Trust Corp raised its holdings in Express Scripts Holding by 12.2% during the second quarter. Northern Trust Corp now owns 11,068,777 shares of the company’s stock worth $706,629,000 after acquiring an additional 1,206,980 shares in the last quarter. Institutional investors and hedge funds own 88.69% of the company’s stock.

Express Scripts Holding Company (NASDAQ ESRX) opened at 59.51 on Monday. The company has a market cap of $34.37 billion, a price-to-earnings ratio of 10.33 and a beta of 0.88. Express Scripts Holding Company has a 52 week low of $55.80 and a 52 week high of $77.50. The stock’s 50 day moving average price is $61.36 and its 200-day moving average price is $62.17.

Express Scripts Holding (NASDAQ:ESRX) last posted its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 EPS for the quarter, topping analysts’ consensus estimates of $1.71 by $0.02. The company had revenue of $25.35 billion for the quarter, compared to analysts’ expectations of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. Express Scripts Holding’s revenue was up .5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.57 EPS. On average, equities research analysts forecast that Express Scripts Holding Company will post $6.99 earnings per share for the current fiscal year.

In other Express Scripts Holding news, VP Everett Neville sold 1,163 shares of the business’s stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total transaction of $71,501.24. Following the sale, the vice president now owns 18,232 shares of the company’s stock, valued at approximately $1,120,903.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Woodrow A. Myers, Jr. sold 3,900 shares of the business’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $63.93, for a total transaction of $249,327.00. Following the sale, the director now directly owns 11,500 shares in the company, valued at approximately $735,195. The disclosure for this sale can be found here. Insiders have sold a total of 5,641 shares of company stock worth $357,317 in the last three months. Insiders own 0.68% of the company’s stock.

ESRX has been the topic of several analyst reports. Jefferies Group LLC set a $72.00 target price on Express Scripts Holding and gave the stock a “buy” rating in a report on Tuesday, August 29th. BidaskClub lowered Express Scripts Holding from a “hold” rating to a “sell” rating in a report on Wednesday, July 12th. Royal Bank Of Canada initiated coverage on Express Scripts Holding in a report on Tuesday, September 19th. They set a “sector perform” rating and a $68.00 target price on the stock. UBS AG lowered Express Scripts Holding from a “market perform” rating to an “underperform” rating in a report on Monday, October 9th. Finally, Raymond James Financial, Inc. reiterated an “underperform” rating on shares of Express Scripts Holding in a report on Monday, October 9th. Six analysts have rated the stock with a sell rating, eleven have issued a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $69.09.

ILLEGAL ACTIVITY WARNING: This piece was reported by Markets Daily and is owned by of Markets Daily. If you are reading this piece on another publication, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.themarketsdaily.com/2017/10/23/perpetual-ltd-has-2-99-million-position-in-express-scripts-holding-company-esrx.html.

Express Scripts Holding Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply